Prevalencia de dermatitis atópica infantil y factores asociados en el área de Pontevedra

La prevalencia de la dermatitis atópica se ha incrementado progresivamente en las últimas décadas, especialmente en los países desarrollados. Describimos la prevalencia de síntomas de dermatitis atópica en Pontevedra en dos grupos de edad, y los posibles factores asociados, mediante un estudio transversal. Obtuvimos 1206 cuestionarios en el grupo de 6-7 años y 1180 en el grupo de 13-14 años. Observamos una prevalencia de dermatitis en el grupo de 6-7 años del 7,4% y del 3,9% en el de 13-14 años. Existió asociación entre diversas variables de dermatitis y el índice de masa corporal, género femenino, antecedentes familiares de rinitis alérgica y dermatitis atópica, estudios de grado superior de la madre, el consumo de paracetamol, el contacto con gatos durante el primer año de vida, el hábitat urbano y la exposición a vehículos pesados

Influence of short implants geometry on primary stability

A correct design is needed in short implants to improve primary stability (PS) in low quality bone. This study aimed to compare PS of double thread and single thread short implants. Thirty implants with single thread design (PHI/SHORT-I) and 30 implants with double thread design (PHIA/SHORT-I) (Radhex®, Inmet-Garnick S.A., Guadalajara, Spain) were placed in 30 randomly selected bovine ribs. PS was assessed in implant stability quotients (ISQ) and periotest values (PV) with Osstell? and Periotest® devices, respectively. Computed tomographies of the ribs were taken and bone quality was evaluated in Hounsfield Units (HU) using Ez3D Plus software (Vatech Co., Korea). Only implants placed in low quality bone according to Misch and Kircos classification were selected (D3 bone: 350-850 HU; and D4 bone: 150-350 HU). Ten implants were not included in the study for being placed in D1 and D2 bone. Finally, 50 implants were selected: 17 and 9 PHI/SHORT-I in D3 and D4 bone respectively, and 15 and 9 PHIA/SHORT-I in D3 and D4 bone respectively. The one-way ANOVA showed statistically significant differences in ISQ (61.35 ± 4.77 in PHI/SHORT-I and 66.43 ± 4.49 in PHIA/SHORT-I, P<0.005) and PV (-2.76 ± 0.8 and -4.11 ± 1.24 respectively, P<0.005) between two implant designs in D3 bone, and statistically significant differences in ISQ (53.44 ± 3.34 in PHI/SHORT-I and 60.56 ± 1.53 in PHIA/SHORT-I, P<0.0001) and PV (1.13 ± 0.95 and -2.5 ± 0.61 respectively, P<0.0001) between two groups in D4 bone. Double thread design short implants resulted to have higher PS in comparison with single thread design short implants in D3 and D4 bone

Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis

Actinic keratoses are cutaneous lesions that appear as the result of the proliferation of atypical keratinocytes. These lesions are considered pre-malignant and they can progress to squamous cell carcinoma. Ingenol mebutate has been approved as an effective treatment for AK on the face and trunk. We studied the local skin reactions to this therapy. Data about local skin reactions were collected in a series of 5 patients with photographic documentation, a visual analog scale, and a ranking of satisfaction of the patient. Moderate to severe reactions were reported in most of patients, but only one stopped treatment early. The short duration of treatment contributes to high adherence to the therapy

Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis

Actinic keratoses are cutaneous lesions that appear as the result of the proliferation of atypical keratinocytes. These lesions are considered pre-malignant and they can progress to squamous cell carcinoma. Ingenol mebutate has been approved as an effective treatment for AK on the face and trunk. We studied the local skin reactions to this therapy. Data about local skin reactions were collected in a series of 5 patients with photographic documentation, a visual analog scale, and a ranking of satisfaction of the patient. Moderate to severe reactions were reported in most of patients, but only one stopped treatment early. The short duration of treatment contributes to high adherence to the therapy

Patients’ Characteristics and Environmental Factors Affecting Skin Cancer Detection: A Multicentre Prospective Study

Abstract is missing (Short communication

Who funds research by Spanish dermatologists? Comparative analysis of articles published in 2008

BACKGROUND: References have been made in the literature to the funding of clinical trials by the pharmaceutical industry. Other types of funding, however, have been less well studied. OBJECTIVE: To describe the sources of funding for research by Spanish dermatology departments published in 2008. MATERIAL AND METHODS: A bibliometric study was performed of the research articles published by Spanish, French, and British dermatology departments and by Spanish rheumatology departments in 2008 according to MEDLINE records. RESULTS: Articles published by Spanish dermatology departments received funding in 36.4% of cases. This percentage is lower than that found for the other groups studied and remained low for all different types of funding. Statistically significant relationships were found between a higher percentage of funding and a higher level of evidence, as well as between a higher level of funding by the pharmaceutical industry and the publication of research into quality of life and pharmacological treatment. Inadequate declaration of funding was observed in 57.1% of articles from Spanish dermatology departments and the role of the sponsor was not declared in any article. Similar findings were obtained for the other groups studied. CONCLUSIONS: The proportion of research articles published by Spanish dermatology departments that receive external funding is low, and this is associated with a lower level of scientific evidence. In order to obtain more external funding, we must improve our competitivenessIntroducción Existen referencias en la literatura acerca de la financiación de los ensayos clínicos por la industria farmacéutica. Otros tipos de financiación han sido menos evaluados. Objetivos Describir la presencia de financiación y su tipo en la investigación realizada por los Servicios de Dermatología españoles en el año 2008. Material y métodos Estudio bibliométrico de los artículos de investigación publicados por Servicios de Dermatología españoles, franceses y británicos y Servicios de Reumatología españoles en el año 2008, indexados en Medline. Resultados El porcentaje de financiación de los artículos de investigación publicados por Servicios de Dermatología españoles fue del 36,4%, siendo este porcentaje menor en comparación con los restantes grupos estudiados, y manteniéndose bajo para los distintos tipos de financiación. Existen relaciones significativas entre un mayor porcentaje de financiación y un mayor nivel de evidencia, así como entre un mayor porcentaje de financiación por la industria y los temas de calidad de vida y de tratamiento farmacológico. En un 57,1% de los artículos de investigación dermatológica española no se declara la financiación de modo adecuado y en ninguno se indicó el papel del financiador. Estos últimos hallazgos fueron similares para los restantes grupos estudiados. Conclusión El porcentaje de financiación externa en los artículos de investigación publicados por Servicios de Dermatología españoles es bajo, y se relaciona con menor nivel de evidencia científica que los restantes grupos estudiados. Se propone la necesidad de aumentar nuestra competitividad para obtener mayor financiación externa